(Q42742767)

English

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability

scientific article published on 14 April 2011

Statements

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability (English)
Magda F Morton
Terrance D Barrett
Jamie Freedman
Michele C Rizzolio
Clodagh E Prendergast
Xiaodong Wu
Veronica Moreno
Jayashree Pyati
Katherine Figueroa
Laurence Cagnon
Guy Lagaud
Luc Ver Donck
Etienne Ghoos
Brett Allison
Michael H Rabinowitz
Nigel P Shankley
14 April 2011
328-336

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit